expired funding Opportunities

Research Grants on Education: Small

The Small Research Grants on Education Program supports education research projects that will contribute to the improvement of education, broadly conceived, with budgets up to $50,000 for projects ranging from one to five years. We accept applications three times per year. This program is “field-initiated” in that proposal submissions are not in response to a specific request for a particular research topic, discipline, design, method, or location. Our goal for this program is to support rigorous, intellectually ambitious and technically sound research that is relevant to the most pressing questions and compelling opportunities in education.

Due date: 30 April 2024

For more information click: https://www.spencer.org/grant_types/small-research-grant

Cures Within Reach: 2024 ReGRoW: Funding for Underresourced Researchers in Low and Lower-Middle Income Countries

Cures Within Reach has released a new request for proposal (RFP) for projects in any unsolved disease and must repurpose an existing off-patent drug, off-patent device, nutraceutical and/or indigenous medicine in a new indication.

Letters of intent due: 2 May, 2024

For more information, click: https://www.cureswithinreach.org/programs/funding-opportunities-rfps/

Pfizer Independent Medical Education: Diagnosis and Diagnostic Tests for Metallo-βLactamase (MBL) Producing Bacterial Infections

This competitive program aims to foster healthcare professional education to support them in making evidence-informed decisions in the diagnosis and management of patients with Metallo-β-Lactamase (MBL) producing bacterial infections.

Deadline: 15 May 2024

For more information click: https://click.icptrack.com/icp/relay.php?r=45085390&msgid=255710&act=84E5&c=1552564&pid=915862&destination=https%3A%2F%2Fcdn.pfizer.com%2Fpfizercom%2F2024-03%2FGMG_2024_HOS_GlobalMBL-ProducingBacterialInfectionsIME.pdf%3FVersionId%3DLT3Sd7ZYOwX6QKW5TouO5VAXX29iH1pf&cf=13590&v=16919ccec51b44362654073af320a1d1e86e20f3c5fd810c52faf6dd61cae614

Advancing The Use of Oral Anticoagulants in Atrial Fibrillation and Venous Thromboembolism

Pfizer and Bristol-Myers Squibb (BMS) are collaborating to provide grant support for continuing professional education in the areas of anticoagulation in atrial fibrillation and venous thromboembolism. We are committed to supporting innovative, independent medical education for healthcare professionals.

Deadline: 6 May 2024

For more information click: https://click.icptrack.com/icp/relay.php?r=45085390&msgid=255654&act=84E5&c=1552564&pid=915858&destination=https%3A%2F%2Fcdn.pfizer.com%2Fpfizercom%2F2024-03%2FGMG_2024_IM_PfizerBMSCVIME.pdf%3FVersionId%3DHa0byQ1sLWKulplNz0rg3whoRDSF_UJa&cf=13590&v=685a6908e39609d26d9f6518603a804e3e7346dc266de84ce96e0cadd42089b6

Call for letters of interest: Addressing neglected areas of sexual and reproductive health and rights in sub-Saharan Africa (ANSRHRA)

Canada’s International Development Research Centre (IDRC) and other funding partners are investing up to CAD19.1 million to fund up to 16 implementation research teams to support gender-transformative implementation research in sub-Saharan Africa. The ANSRHRA Initiative will prioritize projects that address the following five priority areas of sexual and reproductive health and rights (SRHR):

improving access to family planning and contraceptive services
expanding access to safe abortion where legally permitted and post-abortion care
upholding SRHR rights and ensuring access to services for adolescents
preventing and improving services for people experiencing sexual and gender-based violence
strengthening advocacy for SRHR

Successful projects will address at least one of these priority areas of SRHR.

Deadline: 13 May 2024

For more information click: https://idrc-crdi.ca/en/funding/call-letters-interest-addressing-neglected-areas-sexual-and-reproductive-health-and-rights

Scientific Concepts for SANTHE Fellowships (DELTAS Africa)

Scientific project concepts should be for basic, social and clinical or translational science research projects that are focused on HIV and/or TB and associated morbidities. This is a 2 step process consisting on 1) selection of scientific project proposals 2) Recruitment of trainees. University of Zimbabwe is recruiting 1 Postdoctoral fellow.

Deadline: 15 May 2024

To apply click: https://www.cognitoforms.com/ahri1/scientificprojectconceptapplicationdeltasafrica2024

SANTHE Mini Career Development Award

These awards (up to a maximum of $10,000 USD) are accepted on a rolling basis and are designed to help assist early/mid-career researchers to establish new collaborations and initiate new scientific projects. They may also be used for training at international sites.

Any SANTHE Post-doctoral researcher, path-to-independence awardee, or SANTHE supervisor, or working group member may apply.

To apply click: https://www.cognitoforms.com/ahri1/minicareerdevelopmentaward

The Pandemic Fund

The Pandemic Fund has opened its second Call for Proposals (CfP) on December 22, 2023 and is inviting interested Eligible Countries, Regional Entities, and Implementing Entities to develop full proposals for potential projects to be supported by this initial funding. In recognition of the high demand for funding demonstrated in the first CfP, the second CfP continues to prioritize high-impact investments in: 1) early warning and disease surveillance systems, 2) laboratory systems, and 3) strengthening human resources/public health and community workforce capacity, including workforce capacity related to human and animal health, to help countries prevent, prepare for and respond to health emergencies.

Deadline: 17 May 2024

For more information click: https://www.worldbank.org/en/programs/financial-intermediary-fund-for-pandemic-prevention-preparedness-and-response-ppr-fif/funding-opportunities

Wellcome Early-Career Awards

This scheme provides funding for early-career researchers from any discipline who are ready to develop their research identity. Through innovative projects, they will deliver shifts in understanding related to human life, health and wellbeing. By the end of the award, they will be ready to lead their own independent research programme.

Due dates: 21 May and 1 October 2024

For more information click: https://wellcome.org/grant-funding/schemes/early-career-awards

Africa-Europe Foundation

The Africa-Europe Foundation is pleased to announce a Call for Proposals to establish a multiannual research partnership from July 2024 to December 2025. This Call for Proposals is underpinned by the “State of Africa-Europe Report 2024”, produced by the Africa-Europe Foundation and providing a unique benchmarking exercise on the implementation of the Africa-Europe Partnership, including review of the existing policy/financial commitments of the political partnership between the African Union and the European Union.

This Call invites research organisations to deep dive into 3 priority chapters from the ‘State of Africa-Europe Report 2024’, specifically the chapters on:

Sustainable Finance;
Climate and Development;
Science, Education, and Culture.

The Call will serve to establish an “Africa-Europe Research Consortium”, consisting of research organisations from Africa and Europe, including think tanks, research institutes, universities as well as CSOs/NGOs and social enterprises with proven track record in research and policy.

Due date: 23 May 2024

For more information click: https://www.africaeuropefoundation.org/areas-of-action/call-for-proposals-2024:-research/

AGHRB: Malaria vaccine implementation studies in Africa

Apply for funding to undertake implementation research to understand the optimal strategies for roll-out and scale up of the malaria vaccines RTS,S and R21 to ensure that they are deployed in the most effective and equitable way for population health benefit. Research should be conducted in at least two Sub-Saharan African countries, one of which should have a high malaria burden. We will accept applications of all sizes, including large research projects and small to medium-scale applications. You must firstly submit a pre-application to apply for this funding opportunity. Following MRC confirmation your project is within remit, you will be invited to submit a full application.

Due date: 3 June 2024

For more information click: https://www.ukri.org/opportunity/aghrb-malaria-vaccine-implementation-studies-in-africa/

New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)

The purpose of this funding opportunity is to encourage multidisciplinary investigators to develop new approaches or apply existing approaches in novel ways to measure brain activity, connectivity, genomics, or other aspects across the age spectrum of neurodevelopment. The overarching goal is to extend our understanding of brain development and aging, including studies of the neurodevelopmental origins of later health and disease. Research can include healthy human participants of any age; specific clinical groups such as those with cognitive, motor, or affective regulation challenges; and/or animal research on these domains of function. The studies can focus on longitudinal neuroanatomical or functional changes at any level, including genetics/genomics, single cells, connectomics, neural population activity patterns, and others. This funding opportunity is intended to encourage technological and conceptual innovation to improve repeated measures across longer epochs of the lifespan, to better predict outcomes at later ages. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn.

Due dates: 5 June and 5 October 2024

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-24-160.html

Applied global health research: stage one

We’re looking to fund research projects that will lead to tangible change in health policy and practice in the near future through practical, impact focused research. Through our investments in global health research, we aim to:

support a portfolio of high quality, high priority, diverse investments to improve health, encouraging:

o innovation in study design

o multi-disciplinarity to address global challenges

o diverse health topics: prioritise local relevance with potential for global impact

prioritise equitable partnerships
invest in research capacity strengthening
promote co-design and co-production with communities, policy-makers and health practitioners

Due date: 13 June 2024

For more information click: https://www.ukri.org/opportunity/applied-global-health-research/

GenScript Life Science Research Grant Program

GenScript Life Science Research Grant Program is a new initiative dedicated to supporting breakthroughs in life science research areas, including but not limited to those indicated below. This program is designed to empower researchers by providing grant funding earmarked explicitly for purchasing GenScript reagents and services.

Gene and Cell Therapy Development
Antibody Drug Discovery
Vaccine Development

Deadlines: 15 June, 15 September, 15 November 2024

For more information click: https://www.genscript.com/grantprogram.html

New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)

The purpose of this funding opportunity is to encourage multidisciplinary investigators to develop exploratory, highly novel new approaches, or innovative applications of existing approaches, to measure brain activity, connectivity, genomics, or other aspects across the age spectrum of neurodevelopment. The overarching goal is to extend our understanding of brain development and aging, including studies of the neurodevelopmental origins of later health and disease, by improving repeated measures across longer epochs of the lifespan to better predict outcomes at later ages. Research can include healthy human participants of any age; specific clinical groups such those with cognitive, motor, or affective regulation challenges; and/or animal research on these domains of function. The studies can focus on longitudinal neuroanatomical or functional changes at any level, including genetics/genomics, single cells, connectomics, neural population activity patterns, and others. This funding opportunity is intended to encourage technological and conceptual innovation through this high risk, high reward funding mechanism to develop highly innovative ideas that either lack preliminary data or need additional preliminary data. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn.

Due dates: 16 June and 16 Oct 2024

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-24-161.html

Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (“de-implement”) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services (e.g. cancer screening) that may have dropped off amidst the ongoing COVID pandemic are encouraged.

Due dates: 16 June and 16 Oct 2024

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-22-109.html

Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)

Due dates:16 June and 16 Oct 2024

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-22-106.html

NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)

This FOA encourages applications from institutions/organizations that propose to conduct vision-related secondary data analyses utilizing existing database resources. Applications may be related to, but must be distinct from, the specific aims of the original data collection. The NEI supports an extensive portfolio of clinical trials and large-scale epidemiologic research projects wherein numerous data collection activities are required to meet each project’s specific aims. The resultant wealth of data generated by these studies often provides unique, cost-effective opportunities to investigate additional research questions or develop new analytical approaches secondary to a project’s originally-intended purpose. Data are not limited to those collected under NEI support, but such data are of the highest programmatic interest. The purpose of this FOA is for secondary data analysis using existing data sets from vision-related clinical trials, epidemiologic, and other clinical research studies. This FOA may be used to develop new statistical methodologies or test hypotheses using existing data, but this FOA must not be used to support the collection of new data.

Due dates:16 June and 16 Oct 2024

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-22-141.html

Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)

The NIH Common Fund has established the Gabriella Miller Kids First Pediatric Research Program (Kids First) to develop a pediatric research data resource populated by genome sequence and phenotypic data that will be of high value for the communities of investigators who study the genetics of childhood cancers and/or structural birth defects.Kids First has established and continues to develop a Data Resource including a collection of curated genomic and phenotypic data from childhood cancer and structural birth defects cohorts and a central portal where these data and analysis tools are accessible to the research community. Access to these data will promote comprehensive and cross-cutting research and collaboration leading to more refined diagnostic capabilities and ultimately more targeted therapies. This FOA is intended to support meritorious small research projects focused on analyses of childhood cancer and/or structural birth defects genomic datasets generated by the Kids First program and/or associated phenotypic datasets. Development of approaches, tools, or algorithms appropriate for analyzing genomic, phenotypic, and/or clinical data relevant to Kids First may also be proposed.

Due dates: 16 June and 16 Oct 2024

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-23-075.html

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)

The goal of this NOFO is to support applications for novel theory and methods development that enable better understanding of how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations. Approaches should account for interdependencies across scales of biological, social, and ecological organization, make extensive use of theory, modeling, and validation with available large-scale datasets, and may be interdisciplinary drawing from the natural and social sciences.

Due dates: 16 June and 16 Oct 2024

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-23-301.html

Alcohol Health Services Research (R34 Clinical Trial Optional)

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis: (1) increasing access to treatment for AUD, (2) making treatment for AUD more appealing, (3) examining cost structures and insurance systems, (4) conducting studies on dissemination and implementation of existing evidence-based approaches to treating AUD, and (5) reducing health disparities as a means of addressing the treatment gap in AUD for health disparity populations.

Due dates: 16 June and 16 Oct 2024

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-23-252.html

Global Health Policy and Systems Research (HPSR) Projects Call 2

The programme aims to support applied research to strengthen health policy and health systems through:

high quality research on health policy, health services and health systems which improves outcomes for the most vulnerable people in LMICs and addresses issues of health equity
addressing applied health policy and systems research questions which target challenges or evidence gaps prioritised by local stakeholders and policymakers
supporting equitable partnerships and networks between researchers to generate new research knowledge and evidence
involvement and engagement with policymakers, communities, patients and the public, and civil society organisations throughout the research lifecycle
delivering evidence to inform policy and/or practice, for example through engaging with policymakers and informing local, regional or national strategies
capacity strengthening plans for individuals and institutions in LMICs which are proportionate and relevant to the delivery of the proposed activities
including appropriate project management and financial/administrative support
supporting career development for research leaders of the future, i.e. by giving less experienced researchers in LMICs the opportunity to lead or jointly lead on the research proposal with effective mentoring and appropriate support

Due date: 19 June 2024

For more information click: https://www.nihr.ac.uk/funding/global-health-policy-and-systems-research-hpsr-projects-call-2/35549

U21 HSG Funding Opportunities

We offer staff and research students a range of funding options for collaborative projects. We strongly encourage our members to take an interdisciplinary approach involving multiple health themes, working in partnership with at least three member universities. We are pleased to offer three different funding options which include:

international Projects Fund
Research Development Fund
Student Research Fund

Due date: 21 June 2024

For more information click: https://u21health.org/funding-opportunities

BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional)

This Notice of Funding Opportunity (NOFO) solicits applications to develop web-accessible data archives to capture, store, and curate data related to the Brain Research Through Advancing Innovative Neurotechnologies® (BRAIN) Initiative activities. The data archives teams will work with the research community to incorporate software tools that allow users to analyze and visualize the data, and will use appropriate standards to describe the data, but an application with major focus on the creation of such software tools and data standards is not responsive to this NOFO. A goal of this program is to advance research by creating a data archive with appropriate standards and summary information that is broadly available and accessible to the research community for furthering research. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn.

Due dates: 24 June 2024

For more information click: https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-25-110.html

Infectious Disease Award: Understanding dengue and Zika spread, immunity and clinical outcomes

This funding call will support multidisciplinary teams to generate evidence on where dengue and Zika viruses co-circulate and investigate the implications this has on host immune responses and clinical outcomes. Research funded through this award will support global efforts to understand and predict the spread of these pathogens, especially where data are limited. Funded projects will also help to design and implement future interventions to reduce dengue and Zika’s growing burden and impact on health.

Due date: 25 June 2024

For more information click: https://wellcome.org/grant-funding/schemes/infectious-disease-award-understanding-dengue-and-zika-spread

Leveraging Data at Scale to Understand Natural Product Impacts on Whole Person Health (R01 Clinical Trial Not Allowed)

This notice of funding opportunity (NOFO) will support development, adaptation, and/or applications of computational tools to aggregate and analyze orthogonal chemical and/or biological data sets related to natural products with the aim of generating novel testable hypotheses regarding their biological activity and role in the context of whole person health research. Projects must leverage and merge multiple compatible or interoperable sources and/or types of data. Use of artificial intelligence and machine learning approaches is encouraged. This NOFO is part of the Consortium Advancing Research on Botanicals and Other Natural Products (CARBON) Program. Other components of this Program include the Botanical Dietary Supplements Translational Research Teams (RM1) and RFA-AT-24-007 Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data (R24).

Due date: 28 June 2024

For more information click: https://grants.nih.gov/grants/guide/rfa-files/RFA-AT-24-008.html

The Conservation, Food & Health Foundation

The Conservation, Food and Health Foundation seeks to protect the environment, improve food production, and promote public health in Africa, Asia, the Caribbean, Latin America, and the Middle East.

In all of its areas of interest, the Foundation gives priority to projects that have the potential to advance the field, build local capacity, promote replication, influence public opinion and policy, affect systems change, and benefit people beyond the immediate project and its local context.

Due dates: 1 July 2024

For more information click: https://cfhfoundation.grantsmanagement08.com/

Wellcome Career Development Awards

This scheme provides funding for mid-career researchers from any discipline who have the potential to be international research leaders. They will develop their research capabilities, drive innovative programmes of work and deliver significant shifts in understanding related to human life, health and wellbeing.

Due date: 25 July 2024

For more information click: https://wellcome.org/grant-funding/schemes/career-development-awards

Wellcome Discovery Awards

This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding related to human life, health and wellbeing.

Due date: 30 July 2024

For more information click: https://wellcome.org/grant-funding/schemes/discovery-awards

Optimizing Health of Children and Adolescents with Perinatal HIV Exposure (U19 Clinical Trial Optional)

This Notice of Funding Opportunity (NOFO) invites applications to participate in a research program cooperative agreement to support the Optimizing Health of Children and Adolescents with Perinatal HIV Exposure Initiative. The objective of this NOFO is to generate information needed to develop and to test interventions for the early detection and reduction of long-term effects of in utero/perinatal exposure to antiretroviral therapy (ART) and/or HIV among individuals who are HIV exposed but uninfected (IHEU). Investigators with innovative thinking and new approaches to address the public health issues facing IHEUs are encouraged to apply. A multi-program project grant is proposed to answer questions not easily addressed in an R01 or U01. The applications should answer important fundamental questions related to long-term health outcomes for IHEUs. Proposed projects should 1) have a scope that is well matched to the resources and the research objectives, 2) be scientifically meritorious, and 3) complement one another, be synergistic, and support the program’s overall theme.

Due date: 30 July 2024

For more information click: https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-25-004.html

Engaging Survivors of Sexual Violence and Trafficking in HIV and Substance Use Disorder Services (R34 Clinical Trial Optional) – RFA-DA-25-018

The goal of this notice of funding opportunity (NOFO) is to support exploratory research and preliminary interventions to address the interrelated and compounding contextual factors that contribute to substance use and HIV risk among survivors of sex trafficking. This would be accomplished through research that builds new interventions and models of care that can effectively engage survivors of sex trafficking in care for substance use disorder (SUD), HIV, trauma, and other mental health outcomes and addresses key structural and social determinants of health that contribute to risk for sexual trafficking, as well as barriers to and facilitators of escaping continued exploitation. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn.

Due date: 5 August 2024

For more information click: https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-018.html

Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance Use and Mental Health Disorders (R01 Clinical Trial Required)

This notice of funding opportunity (NOFO) seeks applications that coordinate efforts to simultaneously characterize the effects of neuromodulation on brain circuits and behaviors relevant to both substance use disorder (SUD) and mental health disorder (MHD) . Proposed studies are expected to provide a mechanistic perspective on the shared and unique pathophysiology related to SUD and MHD through the causal manipulation of relevant circuit(s) via targeted neuromodulation in human participants. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn.

Due date: 15 August 2024

For more information click: https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-035.html

Merck Stimulating Innovative Research

Since 2018, we are offering a series of research grants to stimulate innovative research in challenging areas of future importance. Grants of up to 500,000 € per year for up to 3 years have been made available. In 2024, grants are available in the area as further specified below.

Discovery strategies for molecular glue degraders and other protein-protein-interaction stabilizers – 1 grant comprising up to 100,000 €/year for up to 3 years with potential further collaboration
Augmented Reality Digital Twin – 1 grant comprising up to 120,000 €/year for 1 year with potential further collaboration
AI-Driven Drug Discovery – up to 3 grants comprising AIDDISON software licenses for one year with potential further collaboration

Due date: 31 August 2024

For more information click: https://www.merckgroup.com/en/research/open-innovation/research-grants.html

Roddenberry Foundation’s Catalyst Fund

The Roddenberry Foundation is seeking applications for its Catalyst Fund. The stages are;

Early Stage: The Catalyst Fund is geared towards small and/or early-stage ideas and projects that need a capital infusion to launch or prove viability. Catalyst awardees are typically piloting a program, venturing into new territory, on the cusp of launching, or pivoting in a new direction.
Big Ideas: The Catalyst Fund supports big ideas or projects that depart from the status quo and require us to look at a problem and its solution in a new light. These big ideas have a high potential for impact across an entire community, city, or country. They tend to leverage existing infrastructure, build on partnerships (public and private), and improve on what’s already out there.

Big ideas push boundaries and challenge convention.

Bold Vision: The Catalyst Fund supports individuals whose vision for change is audacious. Catalyst awardees seek significant, long-term impact and have a vision for how to get there and what needs to get done. They are able to articulate how they plan to make the world better and why. Their vision inspires others and offers a glimpse of a better future.

Due date: Applications are accepted all year round.

For more information click: https://roddenberryfoundation.org/our-work/catalyst-fund/

Fund for Innovation in Development Grants

The Fund for Innovation in Development (FID) is inviting innovators and researchers from around the world to apply for grant funding to more effectively or efficiently address poverty and inequality.

Through flexible grant funding, FID enables innovators and researchers to test new ideas, build rigorous evidence of what works, and scale the highest-impact and most cost- effective solutions.

Due date: Applications are accepted all year round.

For more information click: https://fundinnovation.dev/en

Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications for research training programs to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) to conduct HIV research relevant to the evolving HIV epidemic in their country. This FOA can support training for conducting research in a broad range of HIV research areas across HIV prevention, treatment, care, and quality of life continuum. This includes basic, epidemiologic, clinical, behavioral and social sciences, data science, community-based, implementation, operations, health services, and health systems research. Cross-disciplinary research as well as HIV associated comorbidities and coinfections affecting the HIV epidemic will be supported under this FOA. An application should focus the proposed training program to strengthen research capacity in a defined high priority HIV scientific area aligned with NIH HIV/AIDS research priorities (NOT-OD-20-018) at a specific LMIC institution and collaborating LMIC partner institutions.

Due date: 22 August 2024

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-22-151.html

Fellowships and Scholarships

Africa Research Excellence Fund (AREF)

The AREF Towards Leadership programme aims to empower talented, emerging scientists in Africa to compete successfully for UKRI MRC and other major funding opportunities in global health research. Together we are investing in talented African scientists in Africa, enhancing their global health research and leadership potential. The programme will run between Oct 2024 to Oct 2025, consisting of two residential workshops (opening and closing) and one virtual workshop. The curriculum is designed to support engage and enhance the participants’ capabilities and to empower talented, emerging scientists in Africa to compete successfully on a level playing field for UKRI MRC and other major funding opportunities in global health research. The programme is directed towards to winning grant funding, empowering effective teams, collaborating internationally, influencing stakeholders, and building rewarding research careers.

Deadline for applications: 6 May 2024

For more information, click: https://africaresearchexcellencefund.org.uk/funding-calls/the-aref-mrc-towards-leadership-programme/

Joint Postdoctoral Fellowship in Ethics, Global Health and Infectious Disease

The Johns Hopkins Berman Institute of Bioethics and the Wellcome Centre for Ethics and Humanities at the University of Oxford have established a Collaborative Bioethics Research and Training Program with support from the Wellcome Trust. Through this partnership, we have created joint post-doctoral training opportunities. We are pleased to invite applications from uniquely qualified individuals who are committed to interdisciplinary and transnational collaboration and who have a particular interest in the ethical issues at the intersection of global health and infectious disease. This two-year fellowship will begin September 1, 2024. Deadline: 10 May 2024

For more information click: https://apply.interfolio.com/143815

TWAS-DFG Cooperation Visits Programme – SSA

The TWAS-DFG Cooperation Visits Programme provides postdoctoral researchers from sub-Saharan Africa, including South Africa, with the opportunity to make a three-month ‘Cooperation Visit’ to a research institute in Germany. Such visits must be undertaken within 12 months of the award. The aim of the visit is to initiate research collaboration between African and German scientists with the ultimate goal of developing longer-term links, perhaps through other Deutsche Forschungsgemeinschaft (DFG, or German Research Foundation) programmes. DFG will cover travel expenses and provide subsistence costs for the stay in Germany. The administration and financial operation of TWAS is undertaken by UNESCO in accordance with an agreement signed by the two organizations.

Application deadlines: 5 June 2024.

For more information click: https://www.twas.org/opportunity/twas-dfg-cooperation-visits-programme-ssa

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-22-106.html

NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)

Due dates: 16 Feb, 16 June and 16 Oct 2024

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-22-141.html

Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)

Due dates: 16 Feb, 16 June and 16 Oct 2024

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-23-075.html

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)

Due dates: 16 Feb, 16 June and 16 Oct 2024

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-23-301.html

Alcohol Health Services Research (R34 Clinical Trial Optional)

Due dates: 16 Feb, 16 June and 16 Oct 2024

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-23-252.html

Fellowships and Scholarships

Call for applications TDR Clinical Research Leadership fellowship programme

TDR will fund fellows employed by academic and research institutions in any low- and middle-income country across the globe (not limited to those in sub-Saharan Africa) to be placed in pharmaceutical companies, product development partnerships (PDPs) and academic-affiliated research organizations, in Africa, America, Asia, Europe and Latin America, to train and develop new research skills on infectious diseases. Successful applicants are placed from 6 to 12 months in Training Partner Organisations (TPOs) and receive a reintegration plan for 12 months at their home institutions. Fellowship duration will be based on the proposed targeted training offered by each TPO.

Deadline for applications: 19 February 2024 at 17:00 (CET)

For more information, click: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/file:///Users/thokozilemashaah/Downloads/final-call-2024-crl.pdf

Georg Forster Research Fellowship for Sustainable Development

The Alexander von Humboldt Foundation grants the Georg Forster Research Fellowship to researchers in all disciplines from developing and emerging countries (see list of countries, PDF) who have above-average qualifications. With this fellowship the Humboldt Foundation acknowledges the important role of researchers from these countries in achieving the UN’s 17 sustainable development goals and thus provides them with sponsorship that is equivalent to the Humboldt Research Fellowship. The Georg Forster Research Fellowship enables you to conduct your own research at various stages of your career in collaboration with a host at a German research institution of your choice.

Application deadlines: The Selection Committee responsible for reviewing applications to this programme meets every February, June and October.

For more information click: https://www.humboldt-foundation.de/en/apply/sponsorship-programmes/georg-forster-research-fellowship

Stanford African Scholars in Global Health Program

The Stanford Center for Innovation in Global Health is pleased to announce that applications will open on Feb. 5, 2024 for the first two cohorts of the Stanford African Scholars in Global Health (SASH) program.

For this unique fellowship focused on bidirectional learning and equitable partnerships, selected fellows will spend six weeks at Stanford during the 2024-25 academic year to develop a skill to help improve a specific health outcome at their institution. Cohort 1 will be at Stanford January – February 2025; Cohort 2 will travel from April – May 2025. While at Stanford, fellows will be appointed as Visiting Instructors and will have the opportunity to earn Continuing Medical Education credit. They will then receive a generous Pfizer grant of up to $50,000 and ongoing mentorship for 12-18 months to implement a clinical improvement project at their home institution, building upon the skills developed at Stanford. The fellowship will culminate with a presentation at a convening to be held in an African country at a later date.

Deadline: February 25, 2024

For more information click: https://globalhealth.stanford.edu/education/applications-for-the-stanford-african-scholars-in-global-health-program-open-feb-5.html/

Call for Applications: Postdoctoral & PhD Research Fellowships in Population Health Innovation

Stellenbosch University (SU) is firmly committed to the pursuit of knowledge, research and innovation, in service of society. We provide a world-class centre for learning and development, which is globally relevant, yet rooted in the upliftment and transformation of our local communities. The Population Health Innovation program at the Centre for Epidemic Response and Innovation (CERI) is currently seeking to employ outstanding post-doctoral and PhD researchers to undertake cutting edge research in three areas:

Quantification of the shifts in burden of HIV incidence and underlying viral load patterns in a full population cohort in KwaZulu-Natal, South Africa
A cluster randomized controlled trial to increase uptake of HIV pre-exposure prophylaxis among men in Eastern Zimbabwe
Use of mobile phone GPS trace data for predicting HIV risk among mobile populations.

Minimum requirements for the Postdoctoral research fellowships:

PhD in Biostatistics, Epidemiology, Econometrics, Data Science, Geography, Mathematical Modelling or a closely related quantitative field
Several high-quality publications as a first author
PhD must have been obtained within the last 5 years

Minimum requirement for the PhD fellowships:

Masters in Biostatistics, Epidemiology, Econometrics, Data Science, Geography, Mathematical Modelling or a closely related quantitative field

For more information, contact Prof. Frank Tanser ftanser@sun.ac.za

Deadline for applications: 1st March 2024

For more information click: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/file:///Users/thokozilemashaah/Downloads/2024%20Postdocs%20advert%20PHP.pdf

OWSD Early Career Fellowship – The 2024 Call for Applications is now open.

The OWSD Early Career Fellowship is a prestigious award of up to USD 50,000 offered to women who have completed their PhDs in Science, Technology, Engineering and Mathematics (STEM) subjects and are employed at an academic or scientific research institute in one of the listed Science and Technology Lagging Countries (STLCs). The OWSD Early Career fellows are supported to establish environments at their institutions where they can maintain an international standard of research and attract scholars from all over the world to collaborate.

Deadline for completed online applications: 14 March 2024 (at 23:59 Rome time)

For more information click; https://owsd.net/career-development/early-career-women-scientists-ecws-fellowships

L’Oréal-UNESCO L’Oréal For Women in Science Young Talent program Sub-Saharan Africa – Call for Application 2024

The Fondation L’Oréal and UNESCO launch the 15th edition of the L’Oréal-UNESCO For Women in Science Young Talents – Sub-Saharan Africa program, to support young women scientists. In 2024, 30 endowments will be offered for the Sub-Saharan Africa region: Doctorate: €10 000 Post-doctorate: €15 000

Deadline for applications: 15 March 2024

For more information click: https://www.forwomeninscience.com/challenge/show/92

Global Grand Challenges: Strengthening African National Regulatory Authorities Data Systems to Enhance and Track Performance

Applications are invited from African National Regulatory Agencies (NRAs). Each proposal should be submitted by one primary applicant, but the awards require active collaboration between at least two NRAs per application. In addition, proposals should address at least two (2) of the following categories:

Regulatory review process management:

Create or improve regulatory digital data management systems and end-to-end processes including structured approaches to data generation, analysis, sharing at the regional level. and reporting of KPIs. Priority will be given to proposals including a solid plan for reporting on KPIs, this includes:

regulatory timelines for national marketing authorization,
clinical trial applications,
facilitated regulatory pathways; we would prioritize proposals including REC products, WHO PQ CRP, global pathway (and AMA pathways in future)

Design and structure data management systems that contribute to NRAs achieving WHO ML3/WLA status along with other important efforts addressing the rest of the GBT requirement outside of performance management.

Applications closing deadline: January 31, 2024

For more information, click: https://gcgh.grandchallenges.org/challenge/strengthening-african-national-regulatory-authorities-data-systems-enhance-and-track

Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

Applications closing deadline: February 5, 2024

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-22-105.html

Microbial-based Cancer Imaging and Therapy – Bugs as Drugs (R01 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) solicits grant applications proposing to utilize bacteria, archaebacteria, bacteriophages, or other non-oncolytic viruses and their natural products to study the underlying mechanisms of the complex interactions between microorganisms, tumors, and the immune system, and to explore their clinical potential for cancer imaging, therapeutics or diagnostics. Projects can focus on using microorganisms as anti-tumor agents, as activators of anti-tumor immunity, or as delivery vehicles for treatment, diagnosis, or imaging, complementing or synergizing with existing tools and approaches. This FOA will support basic mechanistic and preclinical studies in cell culture and animal models. Applicants are encouraged to address both the microbial and tumor aspects of microbial tumor interactions relevant to microbial-based cancer therapy (including therapies for oral cancer), tumor imaging, tumor detection, or diagnosis.

Applications closing deadline: February 5, 2024

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-22-085.html

Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical Trial Not Allowed)

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this NIDA R25 program is to support training and educational activities for responsible analyses of complex large-scale data involving brain, behavioral, genomic, and socioenvironmental data that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral, and clinical research needs.

Courses for Skills Development
Curriculum or Methods Development

Applications closing deadline: 8 February 2024

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-24-027.html

NSF-Mercury Project Partnership

A pathbreaking $20 million partnership with the National Science Foundation is advancing the scientific frontier of building vaccination demand and a healthier information environment. The Mercury Project is proud to join with the National Science Foundation in a path-breaking $20M partnership to support social and behavioral science R&D designed to identify interventions with the potential to increase vaccination demand and other health behaviors grounded in science-based public health guidance. This innovative partnership will support research teams seeking to evaluate online or offline interventions to increase vaccination demand and other positive health behaviors, including by targeting the producers and/or consumers of inaccurate health information and/or by increasing confidence in reliable health information. We welcome proposals for evaluations sited in the United States, Africa, Asia, and/or Latin America and the Caribbean.

To apply for funding through the NSF-Mercury Project partnership, investigators may apply to any of the NSF programs. Proposals should adhere to NSF program deadlines and submission requirements, including the proposal preparation guidelines contained in the NSF Proposal & Award Policies & Procedures Guide (PAPPG).

For more information on the NSF programs and deadlines click: https://www.ssrc.org/programs/the-mercury-project/nsf-mercury-project-partnership/

Innovations to Prepare for Future Epidemics and Pandemics

CEPI’s Innovations to Prepare for Future Epidemics and Pandemics Call for Proposals aims to support CEPI’s mission by advancing a broad range of vaccine innovations for pathogens with epidemic or pandemic potential, including novel pathogens capable of infecting and causing disease in humans (i.e., Disease X). It will support vaccine research, development and manufacturing innovations for CEPI’s priority pathogens and contribute towards the 100 Days Mission, thereby helping the world prepare for known and future epidemic and pandemic threats. It initially invites applications across three Focus Areas:

Focus Area 1: advancing innovative rapid-response vaccine platforms that can transform the response to a future Disease X.
Focus Area 2: developing new vaccine candidates against CEPI priority pathogens with epidemic or pandemic potential and viral families.
Focus Area 3: advancing manufacturing innovations that improve vaccine scalability and equitable access.

Application deadlines: CEPI welcomes proposals for Focus Areas 1 and 2 on a rolling basis through 2026. Proposals for Focus Area 3 can be submitted through 12 February 2024. Call deadlines may be subject to amendment.

For more information click: https://cepi.net/get_involved/cfps/?swcfpc=1&learn-more-9166=2

National Eye Institute (NEI) Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed)

The NEI supports large-scale clinical vision research projects, including randomized clinical trials and epidemiologic studies on eye/vision conditions. At the time of submission, applications requesting support for these activities are expected to provide detailed information regarding the study rationale, design, analytic techniques, protocols and procedures, facilities and environment, organizational structure, and collaborative arrangements. This information is best conveyed in a Manual of Procedures (MOP), the development of which represents a costly and time-consuming activity. This clinical research planning grant funding opportunity supports applicants in their planning efforts to conduct collaborative clinical research. The grant may be used to support the development of a MOP, as well as to conduct preliminary studies to refine study procedures or document recruitment potential. The grant must not be used to generate data on the effects of a proposed intervention. This NEI FOA is applicable to both epidemiologic and clinical trial research studies.

Application deadline: 16 February 2024

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-22-128.html

Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)

This FOA encourages applications at the intersection of HIV and aging by addressing two overarching objectives: 1) to improve understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and 2) to improve approaches for testing, prevention, and treatment of HIV infection, and management of HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying our current understanding of aging science. Applications appropriate to this FOA should be consistent with the scientific priorities outlined by the NIH Office of AIDS Research (OAR).

Applications closing deadline: 7 January 2024

For more information, click: https://grants.nih.gov/grants/guide/pa-files/PAR-21-068.html

Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)

This FOA encourages applications at the intersection of HIV and aging by addressing two overarching objectives: 1) to improve understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and 2) to improve approaches for testing, prevention, and treatment of HIV infection, and management of HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying our current understanding of aging science. Studies that move the science of HIV and aging into new directions with little or no preliminary data are appropriate for this activity code. Applications appropriate for this FOA should be consistent with the scientific priorities outlined by the NIH Office of AIDS Research (OAR).

Applications closing deadline: 7 January 2024

For more information, click: https://grants.nih.gov/grants/guide/pa-files/PAR-21-069.html

Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical Trial Not Allowed)

Courses for Skills Development
Curriculum or Methods Development

Applications closing deadline: 8 February 2024

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-24-027.html

NSF-Mercury Project Partnership

For more information on the NSF programs and deadlines click: https://www.ssrc.org/programs/the-mercury-project/nsf-mercury-project-partnership/

Gilead giving in Africa

Grant making in Africa focuses on HIV/AIDS and Viral Hepatitis. Within these therapeutic areas, we provide support for a broad range of activities, including disease awareness; disease prevention; professional education; improving patient access to care; improving quality of care; increasing scientific capacity; strengthening healthcare systems. Across the continent, Gilead works with a number of local partners to help ensure that our medicines reach the people that need them. Our pioneering generic licensing agreements have played a central role in expanding access to high-quality, low-cost HIV treatment throughout Africa.

Grant applications are accepted throughout the year. Funding requests must be submitted a minimum of 8 weeks prior to the start of the activity. The typical grant review timeline can be up to 12 weeks. Formal notifications of all funding decisions are sent in writing by email to the contact listed on the grant application.

For more information click: https://www.gilead.com/purpose/giving/funding-requests/apply-africa

Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is underrepresented or not included in NIDA’s current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.

Due date: 8 March 2024

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-21-208.html

Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 – Clinical Trial Optional)

The purpose of this Notice of Funding Opportunity (NOFO) is to encourage exploratory/developmental research applications that propose to study the development, validation, feasibility, and effectiveness of innovative mobile health (mHealth) interventions or tools specifically suited for low- and middle-income countries (LMICs) that utilize new or emerging technology, platforms, systems, and/or analytics. The overall goal of the program is to catalyze innovation through multidisciplinary research that addresses global health problems, develop an evidence base for the use of mHealth technology to improve clinical and public health outcomes, and strengthen mHealth research capacity in LMICs. This FOA provides support for up to two years (R21 phase) for technology development and feasibility studies, followed by a possible transition to expanded research support (R33 phase) for validation, larger-scale feasibility, and effectiveness studies. Transition to the R33 depends on the completion of applicant-defined milestones, as well as program priorities and the availability of funds. All applicants must address both the R21 and R33 phases.

Due date: 22 March 2024

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-23-318.html

Climate Impacts Awards: Unlocking urgent climate action by making the health effects of climate change visible

The aim of this scheme is to make the impacts of climate change on physical and mental health visible to drive urgent climate policy action at scale. We will fund transdisciplinary teams to deliver short-term, high-impact projects that maximise policy outcomes by combining evidence generation, policy analysis, engaged research approaches and communication strategies.

Career stage: Mid-career researcher, Established researcher

Where your administering organisation is based: Anywhere in the world (apart from mainland China)

Level of funding: Up to £2.5 million

Duration of funding: Up to 3 years

Due date: 3 April 2024

For more information click: https://wellcome.org/grant-funding/schemes/climate-impacts-awards

Request for Applications (RFA): HIV Cure-Related Research in Africa

This announcement invites application(s) from research institution located in Africa to submit research proposals that will (1) support HIV cure-related research in areas of Africa in which there is a high proportion of people living with HIV and (2), expand our understanding of the persistence of non-subtype B HIV in people on antiretroviral therapy (ART) and the mechanisms of post-treatment control of viremia following cessation of ART. The announcement will fund awards of no more than $150,000 per applicant for direct costs for one year. For the purposes of this Competition, applicants should propose projects in the following areas, but not limited to:

Developing and optimizing assays to quantify the levels of full-length, intact HIV proviral DNA in individuals living with non-subtype B HIV and to determine the proportion of intact, rebound competent, and defective provirus
Understanding the virology of the rebound-competent persistent proviral HIV reservoir
Establishment, tissue and cell type distribution
Dynamics, including the clonal proliferation of cells harboring HIV provirus and their decay over time
Studies of the innate and adaptive immune responses to HIV in people living with non-subtype B on ART and the relation of these responses to the rebound-competent viral reservoir, including the sensitivity of the intact reservoir to circulating autologous antibodies and existing T cell responses
Frequency and mechanism of post treatment control in for people living with non-subtype B HIV

Application deadline: 15 April 2024

For more information, click: https://www.crdfglobal.org/funding-opportunities/hiv-cure-related-research-in-africa/ or chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.crdfglobal.org/wp-content/uploads/2024/01/HIV-Cure_Request-For-Applications.pdf

Wellcome Career Development Awards

Career stage: Mid-career researcher

Where your administering organisation is based: UK, Republic of Ireland, Low- or middle-income countries (apart from India and mainland China)

Level of funding: You should ask for your salary (if required) and the resources you need for your research programme – see the ‘What we offer’ section on this page. You will need to justify this in your application.

Duration of funding: Usually 8 years, but may be less for some disciplines and may only be longer if held on a part-time basis.

Application deadline: 11 April 2024

For more information, click: https://wellcome.org/grant-funding/schemes/career-development-awards

Wellcome Discovery Awards

Career stage: Established researcher

Where your administering organisation is based: UK, Republic of Ireland, Low- or middle-income countries (apart from India and mainland China)

Level of funding: You should ask for the resources you need for your research programme – see the ‘What we offer’ section on this page. You will need to justify this in your application. The average size of a Discovery Award is £3.5 million, although we have supported awards from £700,000 to £8 million. Applications above £5 million will be subject to additional due diligence.

Duration of funding: Awards can be up to 8 years, but may be less for some disciplines, and may be longer if held on a part-time basis. The average duration of a Discovery Award is 7 years, although we have supported awards from 3 to 8 years.

Application deadline: 16 April 2024

For more information, click: https://wellcome.org/grant-funding/schemes/discovery-awards

African Research Leaders

Apply for funding to support exceptional early to mid-career African researchers to conduct excellent global health research across sub-Saharan Africa (SSA). Researchers should be supported by an enthusiastic local research environment and by a UK-based partner as part of a partnership between the African and UK institutions. We aim to attract and retain exceptionally talented ‘rising star’ individuals who will lead high quality research on key global health issues pertinent to SSA. Awards will provide support for up to five years and the requested amount should not exceed £750,000 in total. African researchers who already have a well-established record of securing significant international research grant funding or have reached a level of seniority (for example, professor or head of department) should not apply to this funding opportunity.

Application deadline: 24 April 2024

For more information click: https://www.ukri.org/opportunity/african-research-leaders/

Bioimaging Technology Development Awards

This award will fund teams of technology developers and users to create novel bioimaging tools at the cell-tissue scale. Successful teams will develop technologies that answer ambitious research questions or that overcome barriers to bioimaging work in low-resource settings.

Career stage: Leading a research programme

Where your administering organisation is based: UK, Republic of Ireland, Low- or middle-income countries (apart from India and mainland China)

Level of funding: Foundation phase: up to £500k; Scale-up phase: you should ask for the resources you need for your programme – see the ‘What we offer’ section on this page. You will need to justify this in your application.

Duration of funding: Up to 8 years, spanning two phases: a foundation phase for the first 18 months, followed by a scale-up phase up to a maximum of 6.5 additional years.

Application deadline: 30 April 2024

For more information click: https://wellcome.org/grant-funding/schemes/bioimaging-technology-development-awards

Improving Breast Cancer (BC) Quality of Care via Meaningful Capacity Building in Sub-Saharan Africa

Conquer Cancer®, the ASCO Foundation and Pfizer Global Medical Grants are collaborating to offer a Quality Improvement grant funding opportunity to improve the quality of care and to help build capacity to address the needs of breast cancer (BC) patients in Sub-Saharan Africa. This grant program will support innovative projects to improve the quality of BC patient care in the select geographies in the region (please review eligibility section below). Submissions addressing the expressed Areas of Interest with a measurable and sustainable positive impact on patients will be favored by the Scientific Review Committee (SRC). This grant awards program was purposefully developed with the Sub-Saharan Africa Regional Council of ASCO expressly for the patients of the Sub-Saharan region. Conquer Cancer is the lead organization for the review and evaluation of applications. Grant funding will be provided directly from Pfizer. Collectively, up to $1,000,000 is available to fund Quality Improvement projects under this RFP. The maximum grant budget is $80,000 with a term of 24 months.

Due dates: 11 March 2024

For more information click: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://cdn.pfizer.com/pfizercom/2024-01/GMG_2024-ONC-SSA_ASCOCCFBCQI_English.pdf?VersionId=2CT7P5M9zMAL45uH_NG0Kp1FSCOr8lt1

Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

Due dates: 16 June and 16 Oct 2024

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-22-109.html

Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)

Due dates: 16 Feb, 16 June and 16 Oct 2024

Grand Challenges Africa: Catalyzing Equitable Artificial Intelligence (AI) Use to Improve Global Health

Through this call for proposal, we are emphasizing AI solutions that are locally driven and owned hence more relevant to address the needs of people they intend to serve and more likely to be accepted and used by local communities. Responsible global use of AI entails a safe, equitable, transparent, reliable, and beneficial process that is adhered to with a high level of accountability. As the world rapidly moves to seize AI’s opportunities, it is imperative to monitor and mitigate the safety, ethical, equity, and reliability dimensions of AI deployment. This will allow the enormous resilience, creativity, and commitment of researchers, scientists, and policymakers to capture the full capability of AI for lasting good.

Applications closing deadline: November 7, 2023

For more information, click: https://gcgh.grandchallenges.org/challenge/grand-challenges-africa-catalyzing-equitable-artificial-intelligence-ai-use-improve

HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 – Clinical Trial Optional)

This notice of funding opportunity (NOFO) seeks to support research aimed at holistic understanding of inter-individual or between-person differences in human pain conditions, focusing on ‘Whole Person Health’ and enhancing pain treatment and management strategies towards personalized pain medicine. The goal of this NOFO is to support studies that focus on the collection of clinical and/or preclinical data to enable evidence-based modeling and understanding of inter-individual differences and/or heterogeneity of pain occurring with use of pain therapy/management, or with conditions such as a second pain condition, a comorbid health condition, a comorbid mental health condition, or conditions of use / misuse of opioids, alcohol or other substances.

Applications closing deadline: 7 November 2023

For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-24-021.html?utm_medium=email&utm_source=govdelivery

Exploratory Grants for Climate Change and Health Research Center Development (P20 Clinical Trial Optional)

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit P20 planning grant applications for Climate Change and Health Research Centers (CCHRCs). This program will support the development of a transdisciplinary research environment to sustain a program of fundamental and applied research to examine the impacts of climate change on health and to develop action-oriented solutions to protect the health of individuals, communities, and nations from the hazards posed by climate change. This opportunity will allow development of new research teams collaborating with communities and other partners to develop projects that generate data that will build or expand research capacity across a range of thematic scientific areas in support of the four core elements of the NIH’s Initiative in climate heath research: health effects research, health equity, intervention research, and training and capacity building (https://www.nih.gov/sites/default/files/research-training/initiatives/climate-change/nih-climate-change-framework.pdf).

Applications closing deadline: 7 November 2023

For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-23-007.html

Global Grand Challenges: Opportunities to Advance Women’s Health Innovation

As part of the NIH Climate Change and Health Initiative and in collaboration with partner NIH Institutes and Centers, the Center for Global Health Studies (CGHS) of the Fogarty International Center (FIC) within the U.S. National Institutes of Health (NIH) is inviting submissions for a collection of case studies on adaptation strategies that respond to the impact of climate change on public health. For the purposes of this call, adaptation is broadly defined as the process of adjustment to actual and potential climate-led impacts. A case study approach is particularly useful when there is a need to explore in-depth information of a topic or event, identify gaps in current literature, and lessons learnt in multiple settings. This collection is intended to shed light on current knowledge and the potential for research to increase our understanding of climate change adaptation and its impact on health. For instance, research is needed to:

Increase our knowledge of evidence-based adaptation strategies that impact health;
Support the use of innovative research approaches which incorporate quantitative and/or qualitative assessments to better understand the impact of climate adaptation strategies on health outcomes;
Increase our understanding of the impacts of climate change adaptation on health among populations disproportionately impacted by climate change, including those in low- and middle-income countries (LMICs) and under-resourced and marginalized populations globally;
Encourage use of implementation science methodologies to translate adaptation strategies promote the uptake, scale-up, and spread across different contexts; and
Increase opportunities to strengthen climate and health research capacity and support scholars from LMICs to study climate adaptation and health and publish their results.

Applications closing deadline: December 6, 2023

For more information, click: https://gcgh.grandchallenges.org/challenge/opportunities-advance-womens-health-innovation

Strengthening Childcare Models that Advance Women’s Economic Power

This RFP seeks to support evidence-based testing and learning of childcare models in South Asia and Africa that support women’s workforce participation by offering paid work opportunities, reduce and redistribute the burden of unpaid care, support women’s pathways into leadership and/or shift gender norms related to paid work and caregiving. We are looking for projects with an up to 3-year timeline that will achieve at least one of the following objectives:

Support Women’s Economic Opportunity: Advance childcare models that support women’s economic opportunities and/or pathways to leadership by expanding access to childcare services, reduce and redistribute the burden of unpaid care for women, and/or increase decent work opportunities for women in the childcare workforce.
Advancing Evidence: Advance evidence of scalable, sustainable, effective and gender intentional models of childcare, including (but not limited to) pilots which test and compare multiple models of childcare provision, proposals that study applicability and customization of successful care models in target geographies, programs that demonstrate business models which can sustain themselves (either with public or private resources) and/or pilots which help to understand the minimum and optimal levels of childcare quality.
Shift Gender Norms: Accelerate the economic benefits and impacts of childcare for women by shifting gender norms to expand women’s economic agency through (but not limited to): increasing acceptability of women working outside the home, increasing women’s control over newly gained income (inside or outside the care workforce), and shifting social norms regarding acceptability of women using care services.

Applications closing deadline: December 8, 2023

For more information, click: https://gcgh.grandchallenges.org/challenge/strengthening-childcare-models-advance-womens-economic-power

Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk (TranSINDA) (R34 Clinical Trial Not Allowed)

The goal of this Notice of Funding Opportunity (NOFO) is to seek applications proposing a set of planning activities that will lay the groundwork for scientific projects aimed at using animal models and longitudinal research designs to elucidate mechanisms mediating the impact of the early-life social environment on neurobehavioral development and the risk for substance use disorders (SUD) and their comorbidities in adolescence and adulthood. This funding opportunity will support projects of limited scope focused on coordination of a multidisciplinary research team; development of the research framework, design, and approach; and activities that will establish feasibility, validity, and/or other technically qualifying results that, if successful, would support a competitive application for a larger-scale, definitive research project (e.g., R01).

Applications closing deadline: 9 November 2023

For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-24-019.html

Wellcome Mental Health Award: Understanding how anxiety- and trauma-related problems develop, persist and resolve

This award will fund researchers to investigate the causal mechanisms through which brain, body and environment interact over time in the development, persistence and resolution of anxiety- and trauma-related disorders. Knowing more about these mechanisms will help us find better ways to identify these problems and intervene at an early stage.

Applications closing deadline: 14 November 2023

For more information, click: https://wellcome.org/grant-funding/schemes/understanding-anxiety-and-trauma-related-problems#key-dates-de6f

AWS Health Equity Initiative

The AWS Health Equity Initiative will support applications that develop culturally responsive solutions to: 1) increase access to health services, 2) reduce disparities by addressing social determinants of health, 3) leverage data to promote equitable and inclusive systems of care, and 4) advance equity in diagnostics and screening.

Applications closing deadline: 15 November 2023

For more information, click: https://aws.amazon.com/government-education/nonprofits/global-social-impact/health-equity/

Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) encourages exploratory/developmental research grant applications, piloting innovative, collaborative research projects with low- and middle-income country (LMIC) institutions/ scientists on brain and other nervous system-related function and disorders throughout life, relevant to LMICs. Research on the full spectrum of neuro-health, neurological, neuromuscular, sensory, neuropsychiatric, cognitive, behavioral and neurodevelopmental function and disorders may span the full range of science from basic to clinical to translation and implementation research. Scientists in LMIC institutions may partner with scientists in other LMIC institutions and/or U.S. institutions

Applications closing deadline: 15 November 2023

For more information, click: https://grants.nih.gov/grants/guide/pa-files/PAR-21-319.html

Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)

This Funding Opportunity Announcement (FOA) encourages grant applications for the conduct of innovative, collaborative research projects with low- and middle-income country (LMIC) institutions/ scientists on brain and other nervous system function and disorders throughout life, relevant to LMICs. Research on neuro-health and neurological, neuromuscular, sensory, neuropsychiatric, cognitive, behavioral and neurodevelopmental function and disorders may span the full range of science from basic to clinical to translation and implementation research. Scientists in the United States (U.S.) or upper middle-income countries (UMICs) are eligible to partner with LMIC institutions. Scientists in UMICs may partner directly with scientists at other LMIC institutions with or without out a US partner.

Applications closing deadline: 15 November 2023

For more information, click: https://grants.nih.gov/grants/guide/pa-files/PAR-21-311.html

Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) seeks to support multidisciplinary research teams with complementary expertise in HIV and pathobiology, pathophysiology, and/or metabolism in organs, tissues, and/or biological systems of specific interest to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). These teams will comprehensively interrogate fundamental biological mechanisms underlying HIV-associated comorbidities, co-infections, and complications relevant to the mission of the NIDDK and advance progress toward preventing or alleviating them.

Applications closing deadline: 15 November 2023

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/rfa-dk-22-039.html

Fanconi Anemia Research Fund (FARF)

The Fanconi Anemia Research Fund (FARF) seeks to fund interdisciplinary and translational research efforts that will lead to rapid discovery and development of therapies or strategies that treat, control, or cure Fanconi anemia (FA). Research proposals must address one or more of our research priorities:

Top Priority:

To define the pathogenesis of cancers including head and neck and anogenital squamous cell carcinomas that affect persons with FA, and to develop strategies for early detection, prevention, treatment, and cure.

Additional Priorities:

To understand how alteration of the FA genes and their products lead to the clinical manifestations of the disease.
To determine the causes of bone marrow failure, myelodysplasia, and leukemia in individuals with FA, and to develop strategies to prevent, treat and cure these disorders.
To identify practical and proactive management strategies that families and persons with FA can use to develop and maintain a high quality of life.
To support the creation of shared resources, databases, and technologies for the international FA research community.

Letter of interest deadline: not specified

For more information, click: https://www.fanconi.org/explore/apply-for-grant-funding

Gilead

Gilead welcomes funding requests for innovative, high impact projects that relate to at least one of our core therapeutic areas: Our grantmaking in Africa focuses on the following therapeutic areas: HIV/AIDS; Viral Hepatitis. Within these therapeutic areas, we provide support for a broad range of activities, including: Disease awareness; Disease prevention; Professional education; Improving patient access to care; Improving quality of care; Increasing scientific capacity; Strengthening healthcare systems. Funding requests must be submitted a minimum of 8 weeks prior to the start of the activity. The typical grant review timeline can be up to 12 weeks. Formal notifications of all funding decisions are sent in writing by email to the contact listed on the grant application.

Applications closing deadline: Grant applications are accepted throughout the year.

For more information, click: https://www.gilead.com/purpose/giving/funding-requests/apply-africa

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U01) applications for the development of enabling informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI’s Informatics Technology for Cancer Research (ITCR) Program, this FOA focuses on early-stage development from prototyping to hardening and adaptation. Early-stage development is defined for the purpose of this FOA as initial tool development or the significant modification of existing tools for new applications. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, proposed development plans must have a clear rationale on why the proposed technology is needed and how it will benefit the cancer research field. In addition, mechanisms to solicit feedback from users and collaborators throughout the development process must be included.

Applications closing deadline: 17 November 2023

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-23-015.html

Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, analysis, visualization, and interpretation of data across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and cancer health disparities. As a component of the NCI’s Informatics Technology for Cancer Research (ITCR) Program, this FOA focuses on emerging informatics technology, defined as one that has passed the initial prototyping and pilot development stage, has demonstrated potential to have a significant and broader impact, has compelling reasons for further improvement and enhancement, and has not been widely adopted in the cancer research field. To be successful, proposed development plans must have a clear rationale on why the proposed technology is needed and how it will benefit the cancer research field. In addition, mechanisms to solicit feedback from users and collaborators throughout the development process must be included.

Applications closing deadline: 17 November 2023

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-23-016.html

Data Integration and Statistical Analysis Methods (DISAM) (U01 Clinical Trial Not Allowed)

This funding opportunity announcement (FOA) encourages applications for the Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) D43 program for institutional research training programs in low-and middle-income countries (LMICs, as defined by the World Bank classification system). Applications may be for collaborations between institutions in the U.S and an eligible LMIC or may involve just LMIC institutions if there is a previous track record of externally funded research and/or research training programs by the lead LMIC institution. The proposed institutional research training program is expected to sustainably strengthen the NCD research capacity of the LMIC institutions, and to train in-country experts to develop and conduct research on NCDs across the lifespan, with the long-range goal of developing and implementing evidence-based interventions relevant to their countries. Interdisciplinary research training that cuts across NCDs is encouraged.

Applications closing deadline: 20 November 2023

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-23-005.html

Beginning Investigator Grant For Catalytic Research (BIG CAT)

BIG Cat is a premier initiative by the African Organization for Research and Training in Cancer (AORTIC) to build capacity for cancer research in Africa. The goal of BIG Cat program is to aid the next generation of African cancer researchers to base their careers in their home countries and institutions, and to contribute to the overall expansion of capacity for research and training in Africa by generating evidence that will guide practice and policy. BIG Cat was initiated in 2010 by the US National Cancer Institute Center for Global Health (NCI/CGH), and it is now a collaborative effort of AORTIC, American Association for Cancer Research (AACR), and NCI/CGH, with funding support from Partners including academic, industrial and scientific organizations.

The research proposed for funding may be in any area of cancer research, including basic research, clinical research, population-based research and translational research across the cancer care continuum (prevention, early detection, diagnosis, treatment , supportive and palliative care, and survivorship).

Application deadline: 5 December 2023

For more information click: https://www.aacr.org/grants/beginning-investigator-grant-for-catalytic-research-big-cat/?utm_source=salesforce-marketing-cloud&utm_medium=email&utm_campaign=SRGA+-+BIG+Cat&utm_term=Graphic

Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network (PATC³H-IN) Implementation Science Coordinating Center (UM2 Clinical Trial Optional)

This NOFO invites applications to participate in a research program cooperative agreement to support the Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network (PATC3H-IN). The Network will expand and/or improve successes achieved by PATC3H to new geographic settings with limited implementation science (IS) research capacity and/or risk populations who are poorly represented in international adolescent HIV research (e.g. sexual and gender minorities; commercial sex workers; drug users) and stimulate much needed IS research in a neglected area of public health significance: prevention of new HIV infections among adolescents at risk and the identification of, and linkage and retention to care of and long-term viral suppression among youth living with HIV in low-to-middle income countries (LMICs). These settings must have an HIV epidemic density defined by UNAIDS estimates as either a country 1) in which at least 200,000 people are living with HIV and the number has not decreased by more than 5% over the last 2 consecutive years of available data or 2) has an HIV incidence among youth ages 10 to 24 years of 0.01% or more.

Applications closing deadline: 6 December 2023

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-24-009.html

Global Grand Challenges Opportunities to Advance Women’s Health Innovation

The Women’s Health Innovation team at the Bill & Melinda Gates Foundation is looking for innovations and ideas that address opportunities outlined in the Opportunity Map. While not all opportunities in the Opportunity Map are in scope for this RFP, we are looking to fund proposals that address a wide range of issues. The ultimate goal of this RFP is to kickstart work to address gaps in women’s health R&D. The overall objectives are to:

Advance bold ideas that address opportunities in the Opportunity Map
Enhance overall funding and resources for women’s health R&D
Demonstrate effectiveness of investments in women’s health R&D

Application closing deadline: December 6, 2023

For more information click: https://gcgh.grandchallenges.org/challenge/opportunities-advance-womens-health-innovation

Global Grand Challenges Strengthening Childcare Models that Advance Women’s Economic Power

Application closing deadline: December 6, 2023

For more information click: https://gcgh.grandchallenges.org/challenge/opportunities-advance-womens-health-innovation

HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)

The goals of this program are to support locally relevant research in critical areas of HIV-associated non-communicable diseases (NCDs) at Low- and Middle-Income Country (LMIC) Institutions, to enhance research capacity, and to build a network of researchers both within and across LMICs to address this critical burden. This initiative is expected to stimulate new research on the interplay between HIV and development of NCDs in persons living with HIV (PLWH). This includes exploratory studies to uncover the extent to which HIV infection influences the etiopathogenesis of the NCDs; and to identify and develop appropriate approaches for effective diagnosis, prevention, therapeutic interventions and integrated clinical care for PLWH with the comorbid conditions. Applicants should develop their studies in keeping with the NIH HIV/AIDS Research Priorities.

Applications closing deadline: 8 December 2023

For more information, click: https://grants.nih.gov/grants/guide/pa-files/PAR-23-191.html

Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R21 Clinical Trial Not Allowed)

Through this funding opportunity announcement, the National Cancer Institute (NCI) intends to focus on the biological interactions of cancer health disparities in people living with HIV (PLWH) from underrepresented minority groups through basic mechanistic or translational studies to investigate how HIV interacts with health disparities to promote both non-AIDS and AIDS-defining cancer initiation, progression, and the resulting pathogenic disease sequelae.

Applications closing deadline: 15 December 2023

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-057.html

Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional)

The purpose of this Notice of Funding Opportunity (NOFO) is to support Implementation Science for Cancer Control in People Living with HIV (PLWH) in Low- and Middle-Income Countries (LMICs) to accelerate the integration of evidence-based cancer control interventions for PLWH by leveraging existing HIV treatment and prevention infrastructure. Specifically, this NOFOsolicits applications that will identify, understand, and develop strategies to address barriers to the adoption, integration, and sustainability of evidence-based cancer control interventions among PLWH in LMICs and generate data in LMICs that can inform effective and equitable implementation of evidence-based cancer control for PLWH worldwide. Responsive applications should include multi-disciplinary teams of researchers with expertise in HIV, cancer, and implementation science to address the cancer control needs of PLWH populations specific to the proposed LMIC context.

Applications closing deadline: 15 December 2023

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-23-033.html

Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 – Clinical Trial Optional)

The purpose of this NOFO is to solicit Research Project Grant (R01) applications for up to 3 years of support to develop and test interventions to reduce the impact of HIV-associated stigma on the prevention and treatment of HIV infection and/or AIDS, and on the quality of life of People Living with HIV and/or AIDS (PLWH). The NOFO will also support interventions to address the multiple intersecting stigmas and measurement of the stigmas at individual levels. Specifically, this initiative will support intervention research on a) novel stigma reduction strategies that link to increase in care-seeking behavior and/or decrease in transmission, b) reducing the impact of stigma on adolescent and/or youth health, c) strategies to cope with the complex burden of stigmatization due to HIV and one or more comorbidities/coinfections, d) reducing the effects of stigma on, and/or by, family members or caregivers of PLWH and e) development of innovative and improved stigma measurement in the context of implementation of a stigma-reduction intervention. The overall goals are to understand how to reduce stigma as a factor in HIV transmission, to eliminate or mitigate the aspects of stigma that limit beneficial health outcomes for the infected and at-risk individuals and communities, and to conduct exploratory studies to determine the feasibility of stigma-reduction interventions related to HIV prevention, treatment and/or care in Low and Middle-Income Countries (LMICs).

Applications closing deadline: 20 December 2023

For more information, click: https://grants.nih.gov/grants/guide/pa-files/PAR-23-190.html

Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)

Applications closing deadline: 7 January 2024

For more information, click: https://grants.nih.gov/grants/guide/pa-files/PAR-21-068.html

Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)

This FOA encourages applications at the intersection of HIV and aging by addressing two overarching objectives: 1) to improve understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and 2) to improve approaches for testing, prevention, and treatment of HIV infection, and management of HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying our current understanding of aging science. Studies that move the science of HIV and aging into new directions with little or no preliminary data are appropriate for this activity code. Applications appropriate for this FOA should be consistent with the scientific priorities outlined by the NIH Office of AIDS Research (OAR).

Applications closing deadline: 7 January 2024

For more information, click: https://grants.nih.gov/grants/guide/pa-files/PAR-21-069.html

Nestle Foundation Training, Pilot and Grants

The Nestlé Foundation initiates and supports research in human nutrition with public health relevance in low-income and lower middle-income countries according to the World Bank classification (see http://www.worldbank.org). The results of the research projects should ideally provide a basis for implementation and action which will lead to sustainable effects in the studied populations as generally applicable to the population at large. They should also enable institution strengthening and capacity building in a sustainable manner in the host country and further cooperation and collaboration between Institutions in developed and developing countries . At present the Foundation’s work is primarily concerned with human nutrition research issues dealing with:

maternal and child nutrition, including breastfeeding and complementary feeding,
macro- and micronutrient deficiencies and imbalances,
interactions between infection and nutrition, and
nutrition education and health promotion.

The Training Grant (TG) Program supports a small research project such as a MSc or PhD thesis project or another training endeavour. The Pilot Grant PG) Program of the Foundation provides support for pilot research that has a high potential to lead to a subsequent full research project grant. Usually the Foundation does not support nutritional survey research. Often to be able to identify areas of problems for potential intervention one has to collect baseline data. A pilot study (pre-study or baseline study) will create the needed data for a larger research project. The PG program may assist this. The pilot-study and PG usually represent the starting point for a later full research grant application (i.e. a Small Research Grant or a Large Research Grant) to the Foundation.

Applications closing deadline: January 10, 2024

For more information, click: https://research.ubuntunet.net/opportunity/nestle-foundation-pilot-grant/

Fellowships and Scholarships

Call for Mentors for the AAS Mentorship Programme

The AAS has set up a Mentorship Programme, a platform where young researchers are guided and supported to thrive in their careers to ultimately become the next generation of research leaders. Experienced professionals are encouraged to apply as Mentors and support talented early-career researchers across Africa. For more information email mentorship@aasciences.africa

Deadline for submissions is 30 September 2023.

For more information, click: https://mentorship.aasciences.africa/

Call for applications – Short Stay Research Fellowships 2023

Africa Platform of Ghent University Association

The Africa Platform of Ghent University Association (GAP) welcomes applications for visiting fellows. As one of the six regional platforms at Ghent University, GAP facilitates and fosters academic collaboration between Ghent University Association and academic institutions in Africa. The Africa Platform hosts five visiting research fellows every year. Awardees will spend a minimum period of two weeks at Ghent University or one of the associated University Colleges.

Short Stay Research Fellowships

The Africa Platform fellowships are aimed at postdoctoral researchers (junior or senior lecturers and professors) who are affiliated with an African higher education or research institution. A bilateral agreement or memorandum of understanding needs to be in place between Ghent University and the African institution. An overview of agreements and MoUs can be found here. With any questions in this regard, please contact Annelies.Verdoolaege@UGent.be.

Applications closing deadline: 1 October 2023

For more information click: https://www.africaplatform.ugent.be/call-applications-short-stay-research-fellowships-2023

Wellcome Early-Career Awards

This scheme provides funding for early-career researchers from any discipline who are ready to develop their research identity. Through innovative projects, they will deliver shifts in understanding that could improve human life, health and wellbeing. By the end of the award, they will be ready to lead their own independent research programme.

Applications closing deadline: 5 October 2023

For more information click: https://wellcome.org/grant-funding/schemes/early-career-awards

Call for Applications: 2024 OWSD-Elsevier Foundation Awards

Prizes for early career women scientists in water, sanitation and hygiene

The applicant must be a woman who has received her PhD in a scientific discipline within the previous ten years and whose current scientific research is related to the area of water, sanitation and hygiene.

Applications closing deadline: 8 October 2023

For more information click: https://owsd.net/call-applications-2024-owsd-elsevier-foundation-awards

Announcing the Global Health Equity Scholars Fellowship

The Global Health Equity Scholars (GHES) Fellowship is a 12-month, NIH-supported, mentored training in global health research designed to address health inequities and improve population health. Hosted by a consortium of Yale University, Stanford University, University of Arizona, and UC Berkeley, the fellowship year typically runs July-June and offers training opportunities in 24 countries. The fellowship is designed for US doctoral students (PhD, DrPH, etc.), US professional students (MD, DDS, DVM, PharmD, etc.), US postdoctoral fellows, and foreign postdoctoral fellows from affiliated institutions in LMICs. The program’s main objective is to train new generations of health researchers and professionals who will be prepared to address the emerging challenges in global health and inequity. These may include health challenges that arise from the world’s burgeoning human settlements known as slums that have developed in urban and rural communities of many LMICs.

Applications closing deadline: 1 November 2023

For more information click: https://globalhealth.stanford.edu/programs/fogarty-ghes/

The Schlumberger Foundation Faculty for the Future fellowships

Faculty for the Future fellowships are awarded to women from developing and emerging economies who are preparing for PhD or post-doctoral study in Science, Technology, Engineering and Math (STEM) disciplines to pursue advanced graduate study at top universities in their disciplines abroad. Launched by the SLB Foundation in 2004, Faculty for the Future has grown to become a community of 863 women from 90 countries. The long-term goal of the Faculty for the Future program is to generate conditions that result in more women pursuing scientific disciplines. Grant recipients are therefore selected as much for their leadership capabilities as for their scientific talents, and they are expected to return to their home countries to continue their careers and inspire other young women. Faculty for the Future grants range from USD 25,000 to 50,000 per year for PhD courses and a maximum of USD 40,000 for postdoctoral studies. Grants may be renewed through to completion of studies subject to performance, self-evaluation and recommendations from supervisors. The amount of the grant awarded depends on the actual costs of studying and living in the chosen location. Eligibility criteria and application process instructions can be found at New and Renewal Grant Application Processes.

Applications closing deadline: 10 November 2023

For more information click: https://www.facultyforthefuture.net/about-program/

African Career Acceleration Fellowships

The Crick Africa Network (CAN) is offering African Career Acceleration Fellowships supported by LifeArc for early-career biomedical scientists to develop translational scientific programmes and become independent scientists. We’re looking for ambitious early-career African scientists who can demonstrate strong scientific and leadership potential, a keen interest in translational science, and a commitment to establishing their own research groups and continuing their careers on the African continent. Our priority areas include

diseases caused by viruses such as HIV, HBV and SARS-CoV-2,
bacteria such as Mycobacterium tuberculosis and Mycobacterium ulcerans,
other bacterial pathogens including AMR-priority pathogens,
that cause diseases such as typanosomiasis, malaria and cryptospoidiosis,
- helminths, and
- other neglected tropical diseases.
Applications to the second round of Crick Africa Network fellowships are now open until 12 November 2023.

For more information click: https://www.crick.ac.uk/research/research-partnerships/strategic-partnerships/crick-africa-network/african-career-acceleration-fellowships

NAEd/Spencer Postdoctoral Fellowship

The Postdoctoral Fellowship supports early-career scholars working in critical areas of educational scholarship. Fellows will receive $70,000 for one academic year of research, or $35,000 for each of two contiguous years, working half-time. Fellows attend professional development retreats and receive mentorship from NAEd members and other senior scholars in their field. Applicants must have had their PhD, EdD, or equivalent research degree conferred between January 1, 2018, and December 31, 2022, to be eligible to apply this year. This fellowship is non-residential, and applications from all disciplines are encouraged. The NAEd/Spencer Postdoctoral Fellowship will fund 25 early-career researchers for the 2024-25 academic year.

Applications closing deadline: 15 November 2023

For more information click: https://naeducation.org/naedspencer-postdoctoral-fellowship-program/

Wellcome Career Development Awards

This scheme provides funding for mid-career researchers from any discipline who have the potential to be international research leaders. They will develop their research capabilities, drive innovative programmes of work and deliver significant shifts in understanding that could improve human life, health and wellbeing.

Applications closing deadline: 16 November 2023

For more information click: https://wellcome.org/grant-funding/schemes/career-development-awards

Wellcome Discovery Awards

This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding that could improve human life, health and wellbeing.

Applications closing deadline: 21 November 2023

For more information: https://wellcome.org/grant-funding/schemes/discovery-awards

Mental Health Award: Finding the right treatment, for the right people, at the right time for anxiety and depression

This call aims to support validation of biological, psychological, social or digital markers to enable stratification in anxiety and/or depression as early as possible. Stratification will allow targeted treatment and ensure that the right people get the right treatment at the right time.

Applications closing deadline: 7 June 2023

For more information, click: https://wellcome.org/grant-funding/schemes/mental-health-award-finding-right-treatment-right-people-right-time-anxiety

International Bioethics Research Training Program (D43 Clinical Trial Optional)

The overall goal of this initiative is to support the mentored training of a sustainable critical mass of bioethics scholars in low and middle-income country (LMIC) research intensive institutions with the capabilities to conduct original empirical or conceptual ethics research that addresses challenging issues in health research and research policy in these countries as well as provide research ethics leadership to their institutions, governments and international research organizations. FIC will support LMIC-U.S. collaborative institutional bioethics doctoral and postdoctoral research training programs that incorporate mentored research, advanced theoretical didactic courses and ethics career skills training components to prepare multiple individuals for positions of ethics scholarship and leadership in health research institutions in LMICs.

This Funding Opportunity Announcement (FOA) allows appointment of Trainees (D43) proposing to serve as the lead investigator of an independent clinical trial; or proposing a separate ancillary clinical trial; or proposing to gain research experience in a clinical trial led by another investigator, as part of their research and career development.

Applications closing deadline: 6 June 2023

For more information, click: https://grants.nih.gov/grants/guide/pa-files/PAR-22-116.html

HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to promote the discovery of candidate biomarkers or biomarker signatures for pain that can be used to facilitate the testing of non-opioid pain therapeutics in Phase II clinical trials. The biomarkers or biomarker signature will be developed through clinical research specifically focused on the identification of pain biomarkers or biosignatures that predict and/or monitor response to pain therapeutics. The resulting biomarkers or biomarker signatures may be focused on a single pain condition or on several pain conditions with common underlying pathophysiology. Applications to identify biomarkers or biomarker signatures that predict or monitor a therapeutic response across several related pain conditions should feature Multiple Principal Investigator (MPI)-led teams that represent each of the related pain conditions and associated clinical networks. The MPI-led teams are expected to decide upon a single set of measures or biomarker modalities including, but not limited to a combination of omics, Quantitative Sensory Testing (QST), actigraphy, Electroencephalography (EEG), digital measures, etc.as components of the biosignature for all pain conditions represented in the application. Applications should feature centralized resource groups that will coordinate clinical trials and standardize all sample or data collection methods, technology development, statistical analysis and algorithm development across the pain conditions under investigation.

Applications closing deadline: 10 July 2023

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-24-018.html?utm_medium=email&utm_source=govdelivery

Fellowships and Scholarships

NAEd/Spencer Postdoctoral Fellowship

The Postdoctoral Fellowship supports early-career scholars working in critical areas of educational scholarship. Fellows will receive $70,000 for one academic year of research, or $35,000 for each of two contiguous years, working half-time. Fellows attend professional development retreats and receive mentorship from NAEd members and other senior scholars in their field. Applicants must have had their PhD, EdD, or equivalent research degree conferred between January 1, 2018, and December 31, 2022, to be eligible to apply this year. This fellowship is non-residential, and applications from all disciplines are encouraged. The NAEd/Spencer Postdoctoral Fellowship will fund 25 early-career researchers for the 2024-25 academic year.

Applications closing deadline: 15 November 2023

For more information click: https://naeducation.org/naedspencer-postdoctoral-fellowship-program/

Wellcome Career Development Awards

Applications closing deadline: 16 November 2023

For more information click: https://wellcome.org/grant-funding/schemes/career-development-awards

AHRI in collaboration with UKZN is recruiting a Post-Doctoral Research Fellow in Biostatics /Epidemiology /Geography.

This two-year postdoctoral position in Professor Tanser and Professor Mwambi’s research group is embedded in a recently awarded National Institute Health R01 grant. The project seeks to develop the next-generation HIV-prevention strategies for poor rural communities in sub-Saharan Africa. The project will: 1) Quantify the shifts in the spatial, temporal and demographic burden of HIV incidence and underlying viral load patterns in a full population cohort in rural South Africa; 2)Harness the changes in the dynamics of the HIV epidemic to design future intervention programs which will maximize HIV incidence reduction based on the dynamic needs of the most vulnerable sub-populations.

The successful candidate will have access to one of the largest ongoing population-based HIV cohorts in the world – the Africa Health Research Institute’s population cohort in rural KwaZulu-Natal, which includes over 90,000 individuals, with individual-level sociodemographic, biological, and clinical record data as well as comprehensive genomics data. Successful candidate will receive a generous tax-free stipend. Once appointed, the successful candidates will be supported to apply for externally funded personal fellowships and grants and develop collaborations/skills for their career development. They will receive mentorship from leading scientists and faculty members in AHRI, who commonly publish in some of the top journals in the field (Science, Nature and Lancet).

The candidate will be based at our state-of-the-art campuses in KwaZulu-Natal which are located in Durban and Somkhele respectively.

Requirements

The minimum qualifications and experience required for these research posts are:

PhD in Epidemiology, Biostatistics, Bioinformatics, Econometrics, Mathematical Modelling, Spatial Analytics or a closely related quantitative field
Several high-quality publications as a first author
Ability to work in a multi-disciplinary team
Excellent written and oral communication skills
Good interpersonal skills and team orientated

How to apply

To apply, email a detailed CV, cover letter indicating the position you are applying for and a research statement describing your research interests to education@ahri.org. For more information you can contact Prof. Tanser frank.tanser@ahri.org at or Prof Mwambi at mwambi@ukzn.ac.za. AHRI reserves the right not to make an appointment. Please consider your application unsuccessful if you have not been contacted within four weeks of the closing date.

Please share within your research groups – more details here.

Application closing date: 17 November 2023

Wellcome Discovery Awards

Applications closing deadline: 21 November 2023

For more information: https://wellcome.org/grant-funding/schemes/discovery-awards

9th Edition – Science by Women

The Women for Africa Foundation (FMxA), in line with its mission of contributing to the development of Africa through the drive of its women, is launching the 9th Edition of SCIENCE BY WOMEN programme, with the aim to promote African women’s leadership in scientific research and technology transfer and to foster the capacity of the research centres in their home countries. The main goal is to enable African women researchers and scientists to tackle the great challenges faced by Africa through research in health and biomedicine, sustainable agriculture and food security, water, energy and climate change. Women’s lives are significantly affected by the repercussions of uncontrolled development; however, social, structural and economic barriers limit their capacity to tackle the great challenges faced by the continent. The gender disparities in science and technology in both the public and private spheres affect Africa’s population as a whole. Narrowing this gap, which has severe consequences on the balanced and sustainable development of African countries, is vital to achieve long-term progress and equal growing.

Applications closing deadline: September 30, 2023

For more information, click: https://mujeresporafrica.es/9th-edition-science-by-women/

IBD Plexus: Academic Request for Proposals

The Crohn’s & Colitis Foundation is excited to release an international request for proposals (RFP) for academic researchers to gain access to IBD patients’ biosamples and / or research-ready datasets housed within IBD Plexus®. The Foundation seeks research proposals that would utilize IBD Plexus biosamples and / or data to facilitate efforts in 4 main areas: 1) identification and / or validation of diagnostics / biomarkers, 2) therapeutic development and optimization 3) disease management 4) disease prevention

Applications closing deadline: Not specified; Proposal Review timelines: October and December 2023

For more information, click: https://www.crohnscolitisfoundation.org/research/grants-fellowships/ibd-plexus

Call for proposals: Case studies to advance research on climate change adaptation strategies and their impact on public health

Increase our knowledge of evidence-based adaptation strategies that impact health;
Support the use of innovative research approaches which incorporate quantitative and/or qualitative assessments to better understand the impact of climate adaptation strategies on health outcomes;
Increase our understanding of the impacts of climate change adaptation on health among populations disproportionately impacted by climate change, including those in low- and middle-income countries (LMICs) and under-resourced and marginalized populations globally;
Encourage use of implementation science methodologies to translate adaptation strategies promote the uptake, scale-up, and spread across different contexts; and
Increase opportunities to strengthen climate and health research capacity and support scholars from LMICs to study climate adaptation and health and publish their results.

Applications closing deadline: October 16, 2023

For more information, click: https://www.fic.nih.gov/About/center-global-health-studies/Pages/climate-change-call-for-proposals.aspx?utm_source=funding-news&utm_medium=email&utm_campaign=funding-news

Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) invites Research Project Grant (R01) applications that propose to study the ethical, legal and social implications (ELSI) of human genome research. Applications may propose studies using either single or mixed methods. Proposed approaches may include but are not limited to data-generating qualitative and quantitative approaches, legal, economic and normative analyses, and other types of analytical and conceptual research methodologies, such as those involving the direct engagement of stakeholders.

Applications closing deadline: October 19, 2023

For more information, click: https://grants.nih.gov/grants/guide/pa-files/PAR-20-254.html

Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) invites Exploratory/Developmental Research Grant (R21) applications that propose to study the ethical, legal and social implications (ELSI) of human genome research. These applications should propose single or mixed methods studies that break new ground, extend previous discoveries in new directions or develop preliminary data in preparation for larger studies. Of particular interest are studies that explore the implications of new or emerging genomic technologies or novel uses of genomic information.

Applications closing deadline: October 19, 2023

For more information, click: https://grants.nih.gov/grants/guide/pa-files/par-20-255.html

Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) invites Small Research Grant (R03) applications to study the ethical, legal and social implications (ELSI) of human genome research. These applications should be for small, self-contained research projects, such as those that involve single investigators. Of particular interest are projects that propose normative or conceptual analyses, including focused legal, economic, philosophical, anthropological, or historical analyses of new or emerging issues. This mechanism can also be used for the collection of preliminary data and the secondary analysis of existing data.

Applications closing deadline: October 19, 2023

For more information, click: https://grants.nih.gov/grants/guide/pa-files/par-20-257.html

Primary Care-Based Screening Tool and Intervention Development for the Detection and Prevention of Abuse and Neglect in Older and Vulnerable Adults With, or at Risk for, Mild Cognitive Impairment and AD/ADRD (R61/R33 Clinical Trial Required)

The purpose of this Notice of Funding Opportunity (NOFO) is to support research that can lead to the development of primary care-based screening tools and early interventions to detect and prevent abuse and neglect (hereafter referred to as “AN”) in older and vulnerable adults living with, or at risk for, mild cognitive impairment (MCI) and Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD). In the interest of supporting early-stage research conducted by interdisciplinary teams that can lead to the development of screening tools and behavioral interventions that can be successfully implemented in primary care settings with diverse patient populations, this NOFO invites five-year, R61/R33 phased award applications. The R61 planning and pilot phase will provide up to two years of funding to support Stage I and Stage III research to develop, modify, and/or adapt, as well as pilot test screening tools and/or behavioral interventions. The R33 implementation phase will provide up to three years of additional funding to support a Stage III, preliminary efficacy study in primary care and primary care-referable settings.

Applications closing deadline: 20 October 2023

For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-24-048.html

German-African Cooperation Projects in Infectiology

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) calls for draft proposals of joint research projects between researchers in Germany and Africa.

The scope of the call includes:

The investigation of neglected tropical infectious diseases in humans and animals including social and behavioural aspects. “Neglected” in this context means that for basic research into these diseases, only very limited funding is available.
The establishment or strengthening of mutually beneficial equal partnerships that allow African researchers to investigate topics of local significance and that open up research opportunities in Africa for German researchers in the long term.
Providing support and funding for the academic and professional careers of young African researchers in their home countries in order to contribute to building research capacities in Africa.
Strengthening research networks within Africa, therefore, several African partners may participate in one project.

Applications closing deadline: 30 October 2023

For more information: https://www.dfg.de/en/research_funding/announcements_proposals/2023/info_wissenschaft_23_56/index.html

Emerging Global Leader Award (K43 Independent Clinical Trial Required)

The purpose of the Fogarty Emerging Global Leader Award is to provide research support and protected time (three to five years) to an early career research scientist from a low- or middle-income country (LMIC) who holds a junior faculty position at an LMIC academic or research institution. This intensive, mentored research career development experience is expected to lead to an independently funded research career at the LMIC institution or in another LMIC. This Funding Opportunity Announcement (FOA) invites applications from LMIC scientists from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of their country under the mentorship of LMIC and U.S. mentors. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development.

Applications closing deadline: 3 November 2023

For more information: https://grants.nih.gov/grants/guide/pa-files/par-21-251.html

Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)

The purpose of the Fogarty Emerging Global Leader Award is to provide research support and protected time (three to five years) to an early career research scientist from a low- or middle-income country (LMIC) who holds a junior faculty position at an LMIC academic or research institution. This intensive, mentored research career development experience is expected to lead to an independently funded research career at the LMIC institution or in another LMIC. This Funding Opportunity Announcement (FOA) invites applications from LMIC scientists from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of their country under the mentorship of LMIC and U.S. mentors. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.

Applications closing deadline: 3 November 2023

For more information: https://grants.nih.gov/grants/guide/pa-files/PAR-21-252.html

Leveraging Social Networks to Promote Widespread Individual Behavior Change (R34 Clinical Trial Optional)

The purpose of this Notice of Funding Opportunity (NOFO) is to invite basic observational or experimental behavioral and/or social science R01 applications that test how intrapersonal and interpersonal mechanisms of behavior change interact with, influence, or are influenced by characteristics of social networks, with implications for health. Research supported through this NOFO will examine at least two levels of analysis: interpersonal processes and social network characteristics. Projects will identify targets for future social network health behavior change interventions across the lifespan, especially in populations in which they are currently largely underdeveloped and untested (e.g., populations in mid- to- late life). Basic research to develop, refine, or optimize measures (i.e., assays) of putative targets (e.g., intra/interpersonal mechanisms of behavior change and/or social network characteristics) is also supported by this NOFO.

Applications closing deadline: 3 November 2023

For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-24-025.html

Leveraging Social Networks to Promote Widespread Individual Behavior Change (R34 Clinical Trial Optional)

This Notice of Funding Opportunity (NOFO) invites R34 applications to support the planning activities necessary to develop social network interventions to promote health across the lifespan, especially in populations in which they are currently largely underdeveloped and untested (such as populations in mid- and late-life). Applications suited to this R34 will focus on planning activities for social network interventions for which a target interpersonal process of behavior change or social network characteristic has already been identified. Planning activities are those activities that are expected to yield necessary and sufficient information to inform final decisions about a social network health behavior change intervention prior to instigation of a hypothesis-driven trial to test a social network intervention. Activities may include, but are not limited to, team-building, protocol development, piloting of systems for data collection and/or management, feasibility and acceptability testing, staff training, and establishing documentation procedures.

Applications closing deadline: 3 November 2023

For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-24-026.html

HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 – Clinical Trial Optional) This notice of funding opportunity (NOFO) seeks to support research aimed at holistic understanding of inter-individual or between-person differences in human pain conditions, focusing on ‘Whole Person Health’ and enhancing pain treatment and management strategies towards personalized pain medicine. The goal of this NOFO is to support studies that focus on the collection of clinical and/or preclinical data to enable evidence-based modeling and understanding of inter-individual differences and/or heterogeneity of pain occurring with use of pain therapy/management, or with conditions such as a second pain condition, a comorbid health condition, a comorbid mental health condition, or conditions of use / misuse of opioids, alcohol or other substances.

Applications closing deadline: 7 November 2023

For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-24-021.html?utm_medium=email&utm_source=govdelivery

Exploratory Grants for Climate Change and Health Research Center Development (P20 Clinical Trial Optional)

Applications closing deadline: 7 November 2023

For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-23-007.html

Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk (TranSINDA) (R34 Clinical Trial Not Allowed)

Applications closing deadline: 9 November 2023

For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-24-019.html

Wellcome Mental Health Award: Understanding how anxiety- and trauma-related problems develop, persist and resolve

Applications closing deadline: 14 November 2023

For more information, click: https://wellcome.org/grant-funding/schemes/understanding-anxiety-and-trauma-related-problems#key-dates-de6f

AWS Health Equity Initiative

Applications closing deadline: 15 November 2023

For more information, click: https://aws.amazon.com/government-education/nonprofits/global-social-impact/health-equity/

Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)

Applications closing deadline: 15 November 2023

For more information, click: https://grants.nih.gov/grants/guide/pa-files/PAR-21-319.html

Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)

Applications closing deadline: 15 November 2023

For more information, click: https://grants.nih.gov/grants/guide/pa-files/PAR-21-311.html

Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)

Applications closing deadline: 15 November 2023

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/rfa-dk-22-039.html

Fanconi Anemia Research Fund (FARF)

Top Priority:

To define the pathogenesis of cancers including head and neck and anogenital squamous cell carcinomas that affect persons with FA, and to develop strategies for early detection, prevention, treatment, and cure.

Additional Priorities:

To understand how alteration of the FA genes and their products lead to the clinical manifestations of the disease.
To determine the causes of bone marrow failure, myelodysplasia, and leukemia in individuals with FA, and to develop strategies to prevent, treat and cure these disorders.
To identify practical and proactive management strategies that families and persons with FA can use to develop and maintain a high quality of life.
To support the creation of shared resources, databases, and technologies for the international FA research community.

Letter of interest deadline: not specified

For more information, click: https://www.fanconi.org/explore/apply-for-grant-funding

Gilead

Applications closing deadline: Grant applications are accepted throughout the year.

For more information, click: https://www.gilead.com/purpose/giving/funding-requests/apply-africa

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

Applications closing deadline: 17 November 2023

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-23-015.html

Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Applications closing deadline: 17 November 2023

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-23-016.html

Data Integration and Statistical Analysis Methods (DISAM) (U01 Clinical Trial Not Allowed)

Applications closing deadline: 20 November 2023

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-23-005.html

Applications closing deadline: 6 December 2023

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-24-009.html

HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)

Applications closing deadline: 8 December 2023

For more information, click: https://grants.nih.gov/grants/guide/pa-files/PAR-23-191.html

Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R21 Clinical Trial Not Allowed)

Applications closing deadline: 15 December 2023

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-057.html

Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional)

Applications closing deadline: 15 December 2023

For more information, click: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-23-033.html

Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 – Clinical Trial Optional)

Applications closing deadline: 20 December 2023

For more information, click: https://grants.nih.gov/grants/guide/pa-files/PAR-23-190.html